ALMB-0168, a novel Cx43 hemichannel agonist monoclonal antibody, for metastatic or unresectable osteosarcoma after standard chemotherapy: A multicenter, open-label, single-arm, phase 1 study

被引：0
|
作者：
Shen, Jingnan
Guo, Wei
Wang, Jin
Xie, Xianbiao
Xie, Lu
Xu, Jie
Jing, Chen
Lin, Jianhua
Li, Xianan
Zhou, Yong
Wang, Guowen
Zhang, Xiaojing
Yao, Weitao
Dong, Yang
Ye, Zhaoming
Wang, Li
Zeng, Yanyan
Wu, Yongyong
Yang, Xiugao
Zhang, Yanfeng
机构：
[1] Sun Yat Sen Univ, Dept Musculoskeletal Oncol, Affiliated Hosp 1, Guangzhou, Peoples R China
[2] Peking Univ, Peoples Hosp, Beijing, Peoples R China
[3] Sun Yat Sen Univ, Canc Ctr, Guangzhou, Peoples R China
[4] Sun Yat sen Univ, Dept Musculoskeletal, Affiliated Hosp 1, Oncol Ctr, Guangzhou, Peoples R China
[5] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Canc Ctr, Wuhan, Peoples R China
[6] Fujian Med Univ, Dept Orthoped, Affiliated Hosp 1, Fuzhou, Peoples R China
[7] Hunan Canc Hosp, Changsha, Peoples R China
[8] Sichuan Univ, West China Hosp, Dept Orthoped, Chengdu, Peoples R China
[9] Tianjin Med Univ, Canc Inst & Hosp, Tianjin, Peoples R China
[10] Liaoning Canc Hosp & Inst, Shenyang, Peoples R China
[11] Zhengzhou Univ, Henan Canc Hosp, Dept Orthoped, Affiliated Canc Hosp, Zhengzhou, Peoples R China
[12] Shanghai Sixth Peoples Hosp, Shanghai, Peoples R China
[13] Zhejiang Univ, Dept Orthoped, Affiliated Hosp 2, Sch Med, Hangzhou, Peoples R China
[14] CSPC Pharmaceut Grp Ltd, Shanghai, Peoples R China
[15] CSPC Pharmaceut Grp Ltd, Beijing, Peoples R China
[16] AlaMab, Phoenixville, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11530
引用
收藏
页数：1
相关论文
共 50 条
  • [21] PD-1 antibody (Camrelizumab) for metastatic EBV positive gastric cancer: A prospective single-arm, open-label, phase 2 trial.
    Qiu, Miaozhen
    Wang, De-Shen
    Sun, Yu-Ting
    Zhao, Qi
    Guan, Wen-Long
    Xu, Rui-hua
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [22] Rituximab therapy for refractory autoimmune bullous diseases: A multicenter, open-label, single-arm, phase 1/2 study on 10 Japanese patients
    Kurihara, Yuichi
    Yamagami, Jun
    Funakoshi, Takeru
    Ishii, Maki
    Miyamoto, Julia
    Fujio, Yumi
    Kakuta, Risa
    Tanikawa, Akiko
    Aoyama, Yumi
    Iwatsuki, Keiji
    Ishii, Norito
    Hashimoto, Takashi
    Nishie, Wataru
    Shimizu, Hiroshi
    Kouyama, Keisuke
    Amagai, Masayuki
    JOURNAL OF DERMATOLOGY, 2019, 46 (02): : 124 - 130
  • [23] Ficonalkib (SY-3505) in Advanced ALK-Positive NSCLC: A Multicenter, Open-Label, Single-Arm, Phase 1/2 Study
    Shi, Yuankai
    Hu, Xingsheng
    Li, Xingya
    Gong, Caifeng
    Wang, Ke
    Li, Yongsheng
    Zhang, Shucai
    Luo, Yongzhong
    Wang, Pingli
    Jiang, Liyan
    Meng, Xiangjiao
    Dong, Xiaorong
    Wang, Huijuan
    Yang, Runxiang
    Mei, Qi
    Liu, Baogang
    Yang, Limin
    Sun, Yinghui
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (06) : 898 - 911
  • [24] A prospective, multicenter, single-arm, open-label, phase 3 study of Lanreotide Autogel (LAN) in Chinese patients with unresectable, locally advanced or metastatic grade 1 or 2 gastroenteropancreatic neuroendocrine tumors (GEP-NETs)
    Lu, M.
    Li, E.
    Cao, D.
    Chen, J.
    Zhang, N.
    Hu, H.
    Zou, J. Y.
    Shi, X.
    Truong, Thanh X. M.
    Shen, L.
    JOURNAL OF NEUROENDOCRINOLOGY, 2023, 35 : 230 - 230
  • [25] Mitoxantrone hydrochloride liposome injection for the treatment of Recurrent/Metastatic head and neck squamous cell Carcinoma: A Multicenter, Open-label, Single-arm, phase 1b study
    Yang, Hang
    Sun, Peng
    Wang, Yu
    Wang, Xicheng
    Liu, Yanyan
    Peng, Jiyong
    Zhou, Hui
    Li, Yajun
    Zhang, Hong
    Hu, Jianbing
    Zhang, Bing
    Lin, Shunhuan
    Yang, Chunwei
    Li, Weidong
    Liu, Yanping
    Ji, Meng
    Zhao, Jinghua
    Xue, Jianfei
    Huang, Jiajia
    Li, Zhiming
    ORAL ONCOLOGY, 2025, 162
  • [26] Efficacy and safety of zimberelimab (GLS-010) monotherapy in patients with recurrent or metastatic cervical cancer: A multicenter, open-label, single-arm, phase II study
    Wu, X.
    Xia, L.
    Wang, J.
    Wang, C.
    Zhang, Q.
    Zhu, J.
    Rao, Q.
    Cheng, H.
    Liu, Z.
    Yin, Y.
    Ai, X.
    Gulina, K.
    Zheng, H.
    Luo, X.
    Chang, B.
    Li, L.
    Liu, H.
    Li, Y.
    Zhu, J.
    ANNALS OF ONCOLOGY, 2022, 33 : S1506 - S1506
  • [27] EFFICACY AND SAFETY OF ZIMBERELIMAB (GLS-010) MONOTHERAPY IN PATIENTS WITH RECURRENT OR METASTATIC CERVICAL CANCER: A MULTICENTER, OPEN-LABEL, SINGLE-ARM, PHASE II STUDY
    Wu, Xiaohua
    Xia, Lingfang
    Wang, Jing
    Wang, Chunyan
    Zhang, Qingming
    Zhu, Jianqing
    Rao, Qunxian
    Cheng, Huijun
    Liu, Zheng
    Yin, Yongmei
    Ai, Xiaohong
    Gulina, Kurban
    Zheng, Hong
    Luo, Xiaoyong
    Chang, Baoping
    Li, Li
    Liu, Haiyan
    Li, Yunxia
    Lou, Ge
    Zhou, Qi
    Zhu, Yanling
    Xiao, Zemin
    Tong, Jiandong
    Wang, Ke
    Chen, Jie
    Wang, Xia
    Song, Lijie
    Wei, Zhixia
    Ye, Yijing
    Zhu, Jiman
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A703 - A703
  • [28] A Single-arm, Multicenter, Open-label Phase 2 Study of Lapatinib as the Second-line Treatment of Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma
    Wuelfing, Christian
    Machiels, Jean-Pascal H.
    Richel, Dirk J.
    Grimm, Marc-Oliver
    Treiber, Uwe
    De Groot, Marco R.
    Beuzeboc, Philippe
    Parikh, Roma
    Petavy, Frank
    El-Hariry, Iman A.
    CANCER, 2009, 115 (13) : 2881 - 2890
  • [29] mFOLFOX6+bevacizumab + PD-1 monoclonal antibody in locally advanced MSS CRC (BASKETII): A prospective, single-arm, open-label, phase II study
    Huang, J.
    He, W.
    Zhao, Y.
    He, F.
    Liu, Z.
    Pei, F.
    Yao, Q.
    ANNALS OF ONCOLOGY, 2024, 35 : S1433 - S1433
  • [30] Safety and efficacy of jaktinib (a novel JAK inhibitor) in patients with myelofibrosis who are intolerant to ruxolitinib: A single-arm, open-label, phase 2, multicenter study
    Zhang, Yi
    Zhou, Hu
    Duan, Minghui
    Gao, Sujun
    He, Guangsheng
    Jing, Hongmei
    Li, Junmin
    Ma, Liangming
    Zhu, Huanling
    Chang, Chunkang
    Du, Xin
    Hong, Mei
    Li, Xin
    Liu, Qingchi
    Wang, Wei
    Xu, Na
    Yang, Haiping
    Lu, Binhua
    Yin, Hewen
    Wu, Liqing
    Suo, Shanshan
    Zhao, Qingwei
    Xiao, Zhijian
    Jin, Jie
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, : 1588 - 1597
12345